ABERRANT METHYLATION OF ONCOSUPPRESSOR GENES DETECTED IN THE PERIPHERAL BLOOD OF PATIENTS WITH CHRONIC HEPATITIS C AND HEPATOCELLULAR CARCINOMA

被引：1
|
作者：
Maurizio, M. Sampietro [1 ]
Fracanzani, A. L. [1 ,2 ]
Tavazzi, D. [1 ]
Cespiati, A. [1 ]
Bertelli, C. [2 ]
Bignamini, D. [2 ]
Valenti, L. [1 ,2 ]
Fargion, S. R. [1 ,2 ]
机构：
[1] Univ Milan, Milan, Italy
[2] Fdn IRCCS Ca Granda Osped Maggiore Policlin, Milan, Italy
来源：
JOURNAL OF HEPATOLOGY | 2011年 / 54卷
关键词：
D O I：
10.1016/S0168-8278(11)60262-6
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
260
引用
收藏
页码：S107 / S107
页数：1
相关论文
共 50 条
  • [21] Insulin-like growth factor 2 gene methylation in peripheral blood mononuclear cells of patients with hepatitis C related cirrhosis or hepatocellular carcinoma
    Couvert, Philippe
    Carrie, Alain
    du Montcel, Sophie Tezenas
    Vaysse, Jenny
    Sutton, Angela
    Barget, Nathalie
    Trinchet, Jean-Claude
    Beaugrand, Michel
    Ganne, Nathalie
    Giral, Philippe
    Chelly, Jamel
    CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY, 2012, 36 (04) : 345 - 351
  • [22] Chemoprevention of Hepatocellular Carcinoma in Chronic Hepatitis C
    Morgan, Timothy R.
    CLINICAL CANCER PREVENTION, 2011, 188 : 85 - 99
  • [23] Hepatocellular carcinoma in patients cured of chronic hepatitis C: Minimal steatosis
    Rocha, Chiara
    Doyle, Erin H.
    Bowman, Chip A.
    Fiel, M-Isabel
    Stueck, Ashley E.
    Goossens, Nicolas
    Bichoupan, Kian
    Crismale, James F.
    Makkar, Jasnit
    Lewis, Sara
    Perumalswami, Ponni V.
    Schiano, Thomas D.
    Hoshida, Yujin
    Schwartz, Myron
    Branch, Andrea D.
    Patel, Neal
    CANCER MEDICINE, 2023, 12 (09): : 10175 - 10186
  • [24] Hepatocellular carcinoma in patients with hemophilia and chronic hepatitis C infection.
    von Auer, Charis
    Heinsdorf', Sandra
    Krause, Manuela
    Miesbach, Wolfgang
    Scharrer, Inge
    BLOOD, 2006, 108 (11) : 92B - 93B
  • [25] Prevention of hepatocellular carcinoma in patients with chronic active hepatitis C and cirrhosis
    Nishiguchi, S
    Shiomi, S
    Nakatani, S
    Takeda, T
    Fukuda, K
    Tamori, A
    Habu, D
    Tanaka, T
    LANCET, 2001, 357 (9251): : 196 - 197
  • [26] Characteristics of patients with chronic hepatitis C who develop hepatocellular carcinoma
    Kuske, Lorenz
    Mensen, Armand
    Muellhaupt, Beat
    Negro, Francesco
    Semela, David
    Moradpour, Darius
    Male, Pierre Jean
    Heim, Markus H.
    Malinverni, Raffaele
    Cerny, Andreas
    Dufour, Jean-Francois
    SWISS MEDICAL WEEKLY, 2012, 142
  • [27] Liver stiffness and the incidence of hepatocellular carcinoma in patients with chronic hepatitis C
    Nakayama, Yuji
    Takeda, Tadashi
    Yasuda, Takahiro
    Nakaya, Mika
    Nakahara, Kenishi
    Fujii, Hideki
    Kobayashi, Sawako
    Iwai, Shuuji
    Enomoto, Masaru
    Tamori, Akihiro
    Sakaguchi, Hiroki
    Habu, Daiki
    Seki, Shuichi
    Kawada, Nonfumi
    GASTROENTEROLOGY, 2007, 132 (04) : A780 - A780
  • [28] Relation of interferon therapy and hepatocellular carcinoma in patients with chronic hepatitis C
    Imai, Y
    Kawata, S
    Tamura, S
    Yabuuchi, I
    Noda, S
    Inada, M
    Maeda, Y
    Shirai, Y
    Fukuzaki, T
    Kaji, I
    Ishikawa, H
    Matsuda, Y
    Nishikawa, M
    Seki, K
    Matsuzawa, Y
    ANNALS OF INTERNAL MEDICINE, 1998, 129 (02) : 94 - 99
  • [29] CONSTRUCTION OF A RISK INDEX FOR HEPATOCELLULAR CARCINOMA IN CHRONIC HEPATITIS C PATIENTS
    Tateishi, R.
    Yoshida, Haruhiko
    Shiina, S.
    Matsuyama, Y.
    Yoshida, Hideo
    Masuzaki, R.
    Sato, T.
    Goto, E.
    Imamura, J.
    Kondo, Y.
    Goto, T.
    Kanai, F.
    Kato, N.
    Omata, M.
    JOURNAL OF HEPATOLOGY, 2009, 50 : S53 - S53
  • [30] Interferon for decreasing the incidence of hepatocellular carcinoma in patients with chronic hepatitis C
    Hayashi, N
    Kasahara, A
    ONCOLOGY, 2002, 62 : 87 - 93
12345